Our Company

Because in medicine there’s no room for compromise.

Integrity in every transaction. Excellence in regulatory compliance. Deep market expertise. And an unwavering commitment to patient safety — this is what defines LumaCina.

1970

Delta West Establishes Site and Portfolio

Founding of the Bentley sterile-injectables site and the initial product portfolio, laying the groundwork for Australian manufacturing expertise.

1990

Portfolio Advanced Under Pharmacia & Upjohn

Expansion of products and quality systems with global development resources, strengthening technical depth and regulatory readiness.

2000

Pfizer Acquires Portfolio and Site

Integration into Pfizer’s global network with investment in capacity, compliance, and registrations across major markets.

2023

Bridgewest Group Acquires Pfizer’s Perth Site and Portfolio

Bridgewest secures legacy product lines and manufacturing capabilities, ensuring continued production to global quality standards.

2023

LumaCina Launches to Grow Product Access

LumaCina is established to manage and expand this trusted portfolio—bringing hospital-grade, Australian-made medicines to new markets around the world.

2025

LumaCina Becomes an Independent Company

LumaCina separates from Bridgewest Perth Pharma, gaining the independence to pursue growth, partnerships, and an expanded export footprint.

company-2
50+ Years of heritage behind our product portfolio, built on a foundation of trusted hospital medicines.
15+ Strategic partnerships established across key global and regional markets.
120+ Years of combined pharmaceutical experience across our leadership team, spanning the U.S., Australia, and Europe.
logo

Our commitment to quality drives everything we do.

  1. Rigorous partner selection and oversight
  2. End-to-end regulatory alignment
  3. Product stewardship and documentation
  4. Secure, compliant distribution